Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Measles vaccine

Generic Name: Measles vaccine

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Phase 3

Active, not recruiting

Posted: 2023/04/03

Sponsor:Sanofi Pasteur, a Sa...

ID:NCT05794230

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Completed

Posted: 2014/02/10

Sponsor:University of North ...

ID:NCT02058927

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

FDA Misses Deadline for Full Approval Decision on Novavax's COVID-19 Vaccine

2 months ago

The U.S. Food and Drug Administration (FDA) has missed its April 1 deadline to decide on granting full approval to Novavax's protein-based COVID-19 vaccine, which currently has Emergency Use Authorization.

Micron Biomedical Advances Needle-Free Vaccine Technology with $43 Million in Funding

5 months ago

Micron Biomedical has secured $43 million in total grant funding, including a recent $7.5 million grant from the Bill & Melinda Gates Foundation to support measles-rubella vaccine development and manufacturing scale-up.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy